Physician profile
Michael Smith
NPI 1396061479
$2,588.45
in general payments reported to CMS, 2019-2025
24 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666 · 2020: $694 · 2021: $86.69 · 2022: $274 · 2023: $266 · 2024: $101 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $867.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $541.27 | 2020-2025 | |
| Skeletal Dynamics INC | $479.44 | 2019 | |
| Depuy Synthes Sales INC. | $192.80 | 2020-2023 | Orthovisc |
| Sonex Health, INC. | $190.65 | 2025 | Sx-One Microknife |
| Amgen INC. | $186.45 | 2024-2025 | Krystexxa |
| Bioventus LLC | $147.16 | 2023 | Durolane, Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $125.41 | 2022 | |
| Horizon Therapeutics Plc | $116.01 | 2022-2023 | Krystexxa |
| Boston Scientific Corporation | $91.67 | 2019-2025 | Spectra Wavewriter, Wavewriter Alpha Prime 16 |
| Pacira Therapeutics, INC. | $88.44 | 2019-2021 | |
| Stryker Corporation | $62.50 | 2025 | Citrefix |
| Endo Pharmaceuticals INC. | $58.02 | 2019-2022 | |
| Wright Medical Technology, INC. | $41.67 | 2019 | |
| Smith+Nephew, INC. | $35.93 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $34.24 | 2022-2025 | Iovera, Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $30.58 | 2022 | |
| Acumed LLC | $29.00 | 2019 | |
| Baudax Bio INC. | $25.24 | 2021 | |
| Axogen | $24.32 | 2020 | |
| Kyowa Kirin, INC. | $21.42 | 2024 | Crysvita |
| Vertex Pharmaceuticals Incorporated | $19.09 | 2025 | |
| Solventum Corporation | $18.07 | 2025 | Activ.A.C. |
| Ermi LLC | $14.95 | 2020 | |
| Pfizer INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.